Skip to content

Oliver Technow named incoming Chair of the Board of BIOTECanada

Following BIOTECanada’s Annual General Meeting, the Board of Directors is pleased to announce Oliver Technow, CEO, BioVectra Inc. as the incoming Chair of the Board, succeeding Gordon McCauley, President and CEO of adMare BioInnovations whose term as Chair has concluded.

Technow brings over 30 years of experience in the global biosciences sector and a proven track record as CEO of BioVectra Inc., a Charlottetown-based, global Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical and biotech companies with full-service solutions for active pharmaceutical ingredients (API) and intermediates.

Scroll To Top